Fabian Falkenbach

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Positron Emission Tomography

Chronic Myeloid Leukemia

Top Venues

World journal of urology

Nature reviews. Urology

This page only lists publications with an associated author ORCID identifier.

Publications

Fabian Falkenbach, Fatima Ahmad-Sterkau, Mykyta Kachanov, Dirk Beyersdorff, Daniel Koehler, Francesca Ambrosini, Gernot Ortner, Tobias Maurer, Markus Graefen, Lars Budäus
Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound. The Prostate (2024)
Fabian Falkenbach, Francesca Ambrosini, Mykyta Kachanov, Gernot Ortner, Tobias Maurer, Daniel Köhler, Dirk Beyersdorff, Markus Graefen, Lars Budäus
PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy? World journal of urology 42 (1) (2024)
Fabian Falkenbach, Mykyta Kachanov, Sami-Ramzi Leyh-Bannurah, Tobias Maurer, Sophie Knipper, Daniel Köhler, Markus Graefen, Guido Sauter, Lars Budäus
Size of lymph-node metastases in prostate cancer patients undergoing radical prostatectomy: implication for imaging and oncologic follow-up of 2705 lymph-node positive patients. World journal of urology 42 (1) (2024)
Fabian Falkenbach, Francesca Ambrosini, Mykyta Kachanov, Gernot Ortner, Tobias Maurer, Daniel Köhler, Dirk Beyersdorff, Markus Graefen, Lars Budäus
PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy? World journal of urology 42 (1) (2024)
Fabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, Mattia Longoni, Andrea Marmiroli, Quynh Chi Le, Zhe Tian, Jordan A Goyal, Nicola Longo, Salvatore Micali, Alberto Briganti, Ottavio de Cobelli, Felix K H Chun, Fred Saad, Shahrokh F Shariat, Lars Budäus, Markus Graefen, Pierre I Karakiewicz
Adverse In-Hospital Outcomes after Radical Prostatectomy in Leukemia History Patients. Cancers 16 (15) (2024)
Fabian Falkenbach, Francesca Ambrosini, Mykyta Kachanov, Gernot Ortner, Tobias Maurer, Daniel Köhler, Dirk Beyersdorff, Markus Graefen, Lars Budäus
PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy? World journal of urology 42 (1) (2024)
Fabian Falkenbach, Mykyta Kachanov, Sami-Ramzi Leyh-Bannurah, Tobias Maurer, Sophie Knipper, Daniel Köhler, Markus Graefen, Guido Sauter, Lars Budäus
Size of lymph-node metastases in prostate cancer patients undergoing radical prostatectomy: implication for imaging and oncologic follow-up of 2705 lymph-node positive patients. World journal of urology 42 (1) (2024)
Fabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, Mattia Longoni, Andrea Marmiroli, Quynh Chi Le, Zhe Tian, Jordan A Goyal, Nicola Longo, Salvatore Micali, Alberto Briganti, Ottavio de Cobelli, Felix K H Chun, Fred Saad, Shahrokh F Shariat, Lars Budäus, Markus Graefen, Pierre I Karakiewicz
Adverse In-Hospital Outcomes after Radical Prostatectomy in Leukemia History Patients. Cancers 16 (15) (2024)
Fabian Falkenbach, Mykyta Kachanov, Sami-Ramzi Leyh-Bannurah, Tobias Maurer, Sophie Knipper, Daniel Köhler, Markus Graefen, Guido Sauter, Lars Budäus
Size of lymph-node metastases in prostate cancer patients undergoing radical prostatectomy: implication for imaging and oncologic follow-up of 2705 lymph-node positive patients. World journal of urology 42 (1) (2024)
Fabian Falkenbach, Sophie Knipper, Daniel Koehler, Francesca Ambrosini, Thomas Steuber, Markus Graefen, Lars Budäus, Matthias Eiber, Lukas Lunger, Flemming Lischewski, Matthias M Heck, Tobias Maurer
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support. World journal of urology (2023)
Fabian Falkenbach, Francesca Ambrosini, Pierre Tennstedt, Matthias Eiber, Matthias M Heck, Felix Preisser, Markus Graefen, Lars Budäus, Daniel Koehler, Sophie Knipper, Tobias Maurer
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer. Cancers 15 (20) (2023)
Fabian Falkenbach, Tobias Maurer
PSMA-targeted fluorescence guidance for robotic-assisted prostatectomy. Nature reviews. Urology (2023)